Top

Manufacturing of Chlorine Test Strips (INSTA-TEST STRIPS Model 600S)

Active

Federal

Response Deadline07/21/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIIN FSHView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

FORT RILEY, KS, 66442-0000, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 14

subcontract

Response DeadlineJul 21

Submission deadline

Response Deadline

07/21/2026, 05:00:00 PM UTCin 6 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIIN FSH

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIIN FSH

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Manufacture of diagnostic test strips for chlorine, bromine, pH, alkalinity, and total hardness in water. Strips must deliver instant results across specified ranges and meet federal packaging and labeling standards.

Similar Contracts

NAICS: 325411

New

DIBBS

KETOROLAC TROMETHAMINEKetorolac Tromethamine Injection, USP 15 mg per mL in prefilled syringes, 24’s per unit, is being procured under contract SPE2DP-26-T-4143 for delivery to Fort Bragg, North Carolina, with a required delivery date of July 13, 2026, and a five-day delivery window. The item is identified by NSN 6505-01-666-2156 and NDC 76045-0107-10, manufactured by FRESENIUS KABI, LLC, and must comply with DLA’s Master List of Technical and Quality Requirements, including Packaging Requirement RP001 and Shelf-life requirement RS016, which mandates a non-extendable 24-month shelf life. All packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and units must be sealed in commercial containers that ensure protection from damage during transit. The product must be shipped by the fastest traceable means, excluding parcel post, and labeled according to current Hazard Communication Standards (29 C.F.R. 1910.1200), including OSHA-compliant Safety Data Sheets and labels, as mandated post-June 2015. The quantity is one unit of issue (PG), with zero variance permitted, and inspection and acceptance occur at the destination. Packaging and palletization must follow DLA specifications, and government identification must not appear on non-accepted supplies. The contract requires full compliance with all applicable DLA technical and quality requirements, which take precedence over ASTM D3951 or other general commercial standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FThe contract is for Rehydration Salts F, a regulated medical product under FDA oversight, requiring confirmation of compliance with marketing requirements including registration, labeling, and Good Manufacturing Practices, though a 510(k) may not be required. The item has a non-extendable 24-month shelf life and must be marked in accordance with the latest edition of Medical Marking Standard No. 1 and MIL-STD-129, with packaging conforming to MIL-STD-2073-1E and DLA packaging requirements. The product is identified by NSN 6505-01-731-1574 and supplier part number 61436, provided by DRIP DROP HYDRATION INC. A total of two cases are to be delivered FOB destination within five days of contract award, with no variance allowed in quantity. Delivery is to Fort Stewart, Georgia, and shipping must occur via the fastest traceable means, excluding parcel post. The required delivery date is July 16, 2026, and the solicitation closes on July 21, 2026. The contract uses the DoD unit of issue and includes specific markings, packaging codes, and government-only identifiers. The contracting officer must submit an EBS referral for FDA product confirmation, including manufacturer and bidder details.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ANALGESIC GEL, TOPICALThe contract specifies the procurement of an analgesic gel for topical use containing 5% menthol USP, supplied in 4 oz tubes with 144 tubes per case, classified as a flammable hazardous material requiring storage at 20–25°C (68–77°F) and protection from excessive heat or open flame. The item is identified by NSN 6505-01-658-7643 with a non-extendable shelf life of 24 months and must be packaged in commercial-grade containers that ensure protection from damage during transport, conforming to Medical Marking Standard No. 1 instead of MIL-STD-129. Shipment of the product must adhere to applicable hazard communication regulations, including the submission of Safety Data Sheets compliant with 29 C.F.R. 1910.1200 prior to award, and each shipment must include an accompanying SDS. Labels must meet OSHA’s revised Hazard Communication Standard aligned with the Globally Harmonized System, and supplier employees must be trained on these requirements. Packaging and transportation must comply with 49 CFR and ICAO regulations due to the flammable nature of the product, and all materials must be marked and documented in accordance with DLA’s hazardous material protocols, including electronic submission of SDS to DLA.MSDS@DLA.MIL. The contract is issued under solicitation SPE2DP-26-T-4115, requiring delivery within 20 days to Waterveciet, NY, and is managed by the Department of Defense’s Medical Supply Chain.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOLBenzocaine and Menthol Lozenge, manufactured by RB Health US LLC and Reckitt Benckiser LLC, is a 15 mg benzocaine and 2.6 mg menthol oral pain reliever in honey lemon flavor, packaged in units of 16 lozenges, with a shelf life of 36 months that is non-extendable. The product must be stored at 20-25°C (68-77°F) and protected from humidity. All medical acquisitions require commercial packaging that ensures protection from damage or breakage, with each unit sealed in an appropriate container and shipped in exterior containers that guarantee safe, low-cost delivery to the destination. Material must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging must comply with DLA’s packaging requirements and palletization standards. The item is identified by NSN 6505017081449 and NDC 63824-0732-16, and is procured across five contract line items totaling 58 package units, each priced at $1.00 per unit, for total contract value of $58.00. Delivery is required within 20 days, FOB destination, with zero variance allowed in quantity, inspection and acceptance occurring at the delivery point. Shipments must be traceable, excluding parcel post, and sent to designated military logistics addresses at Fort Bragg, North Carolina, and Fort Stewart, Georgia. The solicitation, issued by the Department of Defense under contract SPE2DP-26-T-4113, has a response deadline of July 20, 2026, and requires compliance with all technical and quality requirements listed in the DLA Master List.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100 mg in bottles of 9 tablets, are procured under solicitation SPE2DP-26-T-4106 for acute treatment of migraines with or without aura in adults. The product must comply with strict storage requirements of 20 to 25°C (68 to 77°F), protected from light, and carries a non-extendable 24-month shelf life as a Type I (Code M) item. All packaging and marking must adhere to MIL-STD-2073-1E and MIL-STD-129, with palletization following DLA’s RP001 packaging standards and medical marking in alignment with Medical Marking Standard No. 1. The item is regulated by the FDA, requiring buyer referrals for confirmation before award. Three line items total 11 bottles, with delivery dates set for July 15–16, 2026, and a 20-day delivery window. Shipments are to be sent via traceable freight to designated military addresses in APO AE and Hampton, VA, with no parcel post permitted. The contract specifies zero variance in quantity, with inspection and acceptance occurring at destination. The manufacturer is Mylan Pharmaceuticals Inc. under NDC 00378-5632-59 and Golden State Medical Supply, Inc. under NDC 51407-0013-09, with packaging and labeling meeting all defense logistics agency technical and quality requirements referenced in the DLA Master List.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days

View Details